表示问
发表于 2025-3-25 03:50:12
Current Clinical Role of Genetic Profiling in Breast Cancer,ssays in certain subgroups of breast cancer are ongoing. These are the Trial Assigning Individualized Options for Treatment (Rx) (TAILORx) trial, the endocrine-responsive breast cancer (RxPONDER) trial for 21-gene recurrence score and Microarray In Node-negative Disease may Avoid ChemoTherapy (MINDACT) trial using the 70-gene signature.
Callus
发表于 2025-3-25 10:11:25
Biological Subtypes of Breast Cancer, array analysis has provided insights into the dominant driver pathways that effect individual tumors and translate into clinical manifestations of the disease, response to treatment and overall clinical outcome.
食料
发表于 2025-3-25 14:45:40
http://reply.papertrans.cn/20/1906/190556/190556_23.png
Ordnance
发表于 2025-3-25 19:31:23
978-3-662-52074-1Springer-Verlag Berlin Heidelberg 2015
medium
发表于 2025-3-25 23:45:21
Jonathan Strauss,William Small,Gayle E. WoloschakFirst textbook to describe the biological complexities of breast cancer in a way that is relevant to the radiation oncologist.Covers a range of important emerging issues.Offers practical treatment rec
过度
发表于 2025-3-26 03:30:33
http://reply.papertrans.cn/20/1906/190556/190556_26.png
incision
发表于 2025-3-26 06:38:38
https://doi.org/10.1007/978-1-4757-0878-3 array analysis has provided insights into the dominant driver pathways that effect individual tumors and translate into clinical manifestations of the disease, response to treatment and overall clinical outcome.
违法事实
发表于 2025-3-26 08:28:19
https://doi.org/10.1007/978-1-349-11855-7he inherent heterogeneity of the disease. There are three main subtypes which include estrogen and/or progesterone (ER/PR)-positive, epidermal growth factor receptor-2 (ErbB-2/HER2)-positive, and triple negative that lack expression of ER or PR and express wild type levels of ErbB-2. The etiology of
hereditary
发表于 2025-3-26 13:08:04
The Smallholdings and Survival, Several genetic profile assays are already commercially available, and others are being developed and tested. OncotypeDx, a 21-gene assay, and MammaPrint, a 70-gene assay are the most extensively evaluated tests. Currently, three prospective trials to assess the predictive value of gene signature a
output
发表于 2025-3-26 17:36:30
http://reply.papertrans.cn/20/1906/190556/190556_30.png